Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Generic Line > AstraZeneca Launches Dutoprol to Compete With Toprol-XL Generics

Generic Line

April 25, 2012 | Vol. 29 No. 9

AstraZeneca Launches Dutoprol to Compete With Toprol-XL Generics

AstraZeneca (AZ) is launching Dutoprol, a spinoff of its blood-pressure drug Toprol-XL, to compete with generic versions of the older product.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Glenmark Wins Approval for Generic Progestin-Only Contraceptive FDA Approves First Generic of Celestone Soluspan FDA Approves Taro’s Generic Acne Drug Expert: Fewer Innovator Drugs Could Slow Generic Growth

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.